Skip to content

Genetics of Subsequent Coronary Heart Disease

GENIUS-CHD
About
- What is GENIUS-CHD?
- Background & Rationale
Member Cohorts
Organisation
Join Us
News
Documents
Contact

Project Specific Working Groups

This content is for GENIUS members only. Please login or subscribe.

Search for:

Contact us via email: genius.consortium@gmail.com

Latest Articles on Subsequent CAD Risk Research

Gualou xiebai decoction ameliorates cardiorenal syndrome type II by regulation of PI3K/AKT/NF-κB signalling pathway November 17, 2023
CONCLUSIONS: The findings of this study suggest that GXD improves cardiac and renal function in CRS2 rats and that the underlying mechanism involves inhibition of the PI3K/AKT/NF-κB pathway.

Copyright © 2023 GENIUS-CHD — Stout WordPress theme by GoDaddy